Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

Marco Ruella; David M. Barrett; Saad S. Kenderian; Olga Shestova; Ted J. Hofmann; John Scholler; Simon F. Lacey; Jan J. Melenhorst; Farzana Nazimuddin; Jessica Perazzelli; David A. Christian; Christopher A. Hunter; David L. Porter; Carl H. June; Stephan A. Grupp; Saar Gill

doi:10.1186/2051-1426-3-S2-O5

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

Marco Ruella, David M. Barrett, Saad S. Kenderian, Olga Shestova, Ted J. Hofmann, John Scholler, Simon F. Lacey, Jan J. Melenhorst, Farzana Nazimuddin, Jessica Perazzelli, David A. Christian, Christopher A. Hunter, David L. Porter, Carl H. June, Stephan A. Grupp, Saar Gill

Hematology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Article number	O5
Journal	Journal for ImmunoTherapy of Cancer
Volume	3
DOIs	https://doi.org/10.1186/2051-1426-3-S2-O5
State	Published - 2015

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Molecular Medicine
Oncology
Pharmacology
Cancer Research

Access to Document

10.1186/2051-1426-3-S2-O5

Cite this

Ruella, M., Barrett, D. M., Kenderian, S. S., Shestova, O., Hofmann, T. J., Scholler, J., Lacey, S. F., Melenhorst, J. J., Nazimuddin, F., Perazzelli, J., Christian, D. A., Hunter, C. A., Porter, D. L., June, C. H., Grupp, S. A., & Gill, S. (2015). Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. Journal for ImmunoTherapy of Cancer, 3, Article O5. https://doi.org/10.1186/2051-1426-3-S2-O5

Ruella, M, Barrett, DM, Kenderian, SS, Shestova, O, Hofmann, TJ, Scholler, J, Lacey, SF, Melenhorst, JJ, Nazimuddin, F, Perazzelli, J, Christian, DA, Hunter, CA, Porter, DL, June, CH, Grupp, SA & Gill, S 2015, 'Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells', Journal for ImmunoTherapy of Cancer, vol. 3, O5. https://doi.org/10.1186/2051-1426-3-S2-O5

@article{946d468175a04dd0b8407f62291d34c2,

title = "Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells",

author = "Marco Ruella and Barrett, {David M.} and Kenderian, {Saad S.} and Olga Shestova and Hofmann, {Ted J.} and John Scholler and Lacey, {Simon F.} and Melenhorst, {Jan J.} and Farzana Nazimuddin and Jessica Perazzelli and Christian, {David A.} and Hunter, {Christopher A.} and Porter, {David L.} and June, {Carl H.} and Grupp, {Stephan A.} and Saar Gill",

year = "2015",

doi = "10.1186/2051-1426-3-S2-O5",

language = "English (US)",

volume = "3",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

AU - Ruella, Marco

AU - Barrett, David M.

AU - Kenderian, Saad S.

AU - Shestova, Olga

AU - Hofmann, Ted J.

AU - Scholler, John

AU - Lacey, Simon F.

AU - Melenhorst, Jan J.

AU - Nazimuddin, Farzana

AU - Perazzelli, Jessica

AU - Christian, David A.

AU - Hunter, Christopher A.

AU - Porter, David L.

AU - June, Carl H.

AU - Grupp, Stephan A.

AU - Gill, Saar

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=85042878482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042878482&partnerID=8YFLogxK

U2 - 10.1186/2051-1426-3-S2-O5

DO - 10.1186/2051-1426-3-S2-O5

M3 - Article

AN - SCOPUS:85042878482

SN - 2051-1426

VL - 3

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

M1 - O5

ER -

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this